The past couple of decades have witnessed significant progress in technology that has played a key role in improving the different cardiac treatments and patient outcomes. Advancements in biomedicine have led to an increase in the deployment of natural bio polyesters such as polyhydroxyalkanoates (PHA) for an array of applications. As PHAs are biodegradable, biocompatible, and non-toxic, they are used in multiple applications as biomaterials. PHAs are also used in the implantology space as valves and sutures in the tissue engineering field as substitutes for a bone graft and cardiovascular patches. The significant rise in the number of congenital & acquired cardiovascular and soft tissue anomalies, rising demand for biologics for hernia and other soft tissue repair, and rapid progress in biomaterial and tissue engineering are some of the major factors that are expected to drive the cardiovascular & soft tissue repair patch market during the forecast period (2019-2027).
Research and development activities in the cardiovascular & soft tissue repair patch market are on the rise as healthcare providers continue to find new materials that will improve the effectiveness of these patches. Growing adoption of cardiovascular & soft tissue repair patches particularly for cardiac tissue engineering is expected to be a major driver that is projected to steer the global cardiovascular & soft tissue repair patch market past the ~US$ 4.4 Bn mark by the end of 2027.
To know the scope of our report Get a Sample on Cardiovascular & Soft Tissue Repair Patch Market
Cardiovascular diseases are the leading causes of death worldwide and the numbers surge each year. Of all major cardiovascular diseases, the prevalence of myocardial infarction (MI) is the highest. Another major cardiovascular condition that is likely to be a burden on the global healthcare systems is heart failure wherein the heart loses its functional capabilities. While there is no concrete treatment for heart failure, research and development activities continue to open up new opportunities in this field.
Get a glimpse of the in-depth analysis through our Report Brochure
In the past couple of decades, tissue regeneration to enhance cardiac degeneration and mitigate heart failure has emerged as an ideal solution wherein cardiovascular & soft tissue repair patches made of biomaterials are used. Apart from tissue engineering, noteworthy advancements in regenerative medicine have also opened up new opportunities for stakeholders in the cardiovascular & soft tissue repair patch market. Over the past few years, participants of the cardiovascular & soft tissue repair patch market are focusing on the development of biomaterial-based strategies to overcome cardiac regeneration post-myocardial infarction. In the current scenario, the two major techniques deployed for tissue engineering include cardiac patches and in situ gelling systems. Cardiovascular & soft tissue repair patches consist of cells and bioactive molecules that aid in the therapeutic healing and repair of soft tissues. Despite emerging as one of the most reliable and effective tissue engineering techniques, cardiovascular & soft tissue repair patches have received flak, as they require invasive surgeries for implantation. In the past few years, in situ gel systems gaining popularity. However, it could dent the prospects of cardiovascular & soft tissue repair patches in the near future.
Research and development activities have been critical in the field of biomedicine and biomedical engineering. Witnessing the growing demand for efficient solutions to repair or heal the structural changes of the heart post-myocardial infarction treatment has encouraged research and development in the current cardiovascular & soft tissue repair patch market. While stem cell therapies have offered significant promise in providing assistance for cardiac repair, the low retention capacity of the transplanted stem cells poses a major hurdle. Various drawbacks of alternative techniques to aid cardiac repair have encouraged researchers to focus on the discovery of new solutions.
For instance, a group of researchers from the U.S. and South Korea designed a new stretchable cardiovascular & soft tissue repair patch made using a cell-derived extracellular matrix (ECM). According to the researchers, ECM can play an important role in enhancing the adhesion of stem cells and accelerate the recovery process. Investments in research and development activities are expected to grow at a steady pace in the coming years due to which, new therapeutic cardiovascular & soft tissue repair patches are being developed using new biomaterials.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The global cardiovascular & soft tissue repair patch market is expected to grow at an impressive CAGR of ~10% during the forecast period. The market growth can be attributed to a range of factors, including rise in the prevalence of congenital & acquired cardiovascular and soft tissue anomalies and ascending demand for biologics for hernia and a range of other soft tissue repair applications. Stakeholders in the current cardiovascular & soft tissue repair patch market should focus on research and development activities to develop new and effective therapeutic cardiac patches. In addition, developments in the biomaterial and tissue engineering space are further expected to boost the prospects of the market for cardiovascular & soft tissue repair patches.
Cardiovascular & Soft Tissue Repair Patch Market - Segmentation
|
Product |
Synthetic Patch Biologic Patch
|
|
Application |
Cardiovascular Repair
Soft Tissue Repair
|
|
End User |
Hospitals Ambulatory Surgical Centers Specialty Clinics |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Cardiovascular & soft tissue repair patch market is expected to expand at a CAGR of ~10% from 2019 to 2027
Cardiovascular & soft tissue repair patch market to reach valuation of ~US$ 4.4 Bn by 2027
Cardiovascular & soft tissue repair patch market is driven by rise in prevalence of congenital & acquired cardiovascular and soft tissue anomalies
The biologic patch segment accounted for major share of the global cardiovascular & soft tissue repair patch market
Key players in the global cardiovascular & soft tissue repair patch market include W. L. Gore & Associates, Inc., BD, Edwards Lifesciences Corporation, CryoLife, Inc., Baxter Johnson & Johnson (Medical Devices Business Services, Inc.)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cardiovascular & Soft Tissue Repair Patch Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Key Industry Events (product launch and approval, key merger & acquisition, etc.)
5.2. Overview of Cardiovascular and Soft Tissue Repair Patch
5.3. Epidemiology of Cardiovascular Diseases, Soft Tissue Injury, Dural Injuries, Peripheral Injuries, by Region/Country
6. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2027
6.3.1. Synthetic Patch
6.3.2. Biologic Patch
6.3.2.1. Xenogeneic Patch
6.3.2.2. Allogeneic Patch
6.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Product
7. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
7.3.1. Cardiovascular Repair
7.3.1.1. Cardiac Reconstruction
7.3.1.2. Vascular Reconstruction
7.3.2. Soft Tissue Repair
7.3.2.1. Abdominal Wall Reconstruction
7.3.2.2. Thoracic Wall Reconstruction
7.3.2.3. Dural Reconstruction
7.3.2.4. Hernia Repair
7.3.2.5. Others
7.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Application
8. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Specialty Clinics
8.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by End-user
9. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Country/Region
10. North America Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
10.2.1. Synthetic Patch
10.2.2. Biologic Patch
10.2.2.1. Xenogeneic Patch
10.2.2.2. Allogeneic Patch
10.3. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
10.3.1. Cardiovascular Repair
10.3.1.1. Cardiac Reconstruction
10.3.1.2. Vascular Reconstruction
10.3.2. Soft Tissue Repair
10.3.2.1. Abdominal Wall Reconstruction
10.3.2.2. Thoracic Wall Reconstruction
10.3.2.3. Dural Reconstruction
10.3.2.4. Hernia Repair
10.3.2.5. Others
10.4. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Specialty Clinics
10.5. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
11.2.1. Synthetic Patch
11.2.2. Biologic Patch
11.2.2.1. Xenogeneic Patch
11.2.2.2. Allogeneic Patch
11.3. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
11.3.1. Cardiovascular Repair
11.3.1.1. Cardiac Reconstruction
11.3.1.2. Vascular Reconstruction
11.3.2. Soft Tissue Repair
11.3.2.1. Abdominal Wall Reconstruction
11.3.2.2. Thoracic Wall Reconstruction
11.3.2.3. Dural Reconstruction
11.3.2.4. Hernia Repair
11.3.2.5. Others
11.4. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Specialty Clinics
11.5. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
12.2.1. Synthetic Patch
12.2.2. Biologic Patch
12.2.2.1. Xenogeneic Patch
12.2.2.2. Allogeneic Patch
12.3. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
12.3.1. Cardiovascular Repair
12.3.1.1. Cardiac Reconstruction
12.3.1.2. Vascular Reconstruction
12.3.2. Soft Tissue Repair
12.3.2.1. Abdominal Wall Reconstruction
12.3.2.2. Thoracic Wall Reconstruction
12.3.2.3. Dural Reconstruction
12.3.2.4. Hernia Repair
12.3.2.5. Others
12.4. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Specialty Clinics
12.5. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
13.2.1. Synthetic Patch
13.2.2. Biologic Patch
13.2.2.1. Xenogeneic Patch
13.2.2.2. Allogeneic Patch
13.3. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
13.3.1. Cardiovascular Repair
13.3.1.1. Cardiac Reconstruction
13.3.1.2. Vascular Reconstruction
13.3.2. Soft Tissue Repair
13.3.2.1. Abdominal Wall Reconstruction
13.3.2.2. Thoracic Wall Reconstruction
13.3.2.3. Dural Reconstruction
13.3.2.4. Hernia Repair
13.3.2.5. Others
13.4. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Specialty Clinics
13.5. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027
14.2.1. Synthetic Patch
14.2.2. Biologic Patch
14.2.2.1. Xenogeneic Patch
14.2.2.2. Allogeneic Patch
14.3. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027
14.3.1. Cardiovascular Repair
14.3.1.1. Cardiac Reconstruction
14.3.1.2. Vascular Reconstruction
14.3.2. Soft Tissue Repair
14.3.2.1. Abdominal Wall Reconstruction
14.3.2.2. Thoracic Wall Reconstruction
14.3.2.3. Dural Reconstruction
14.3.2.4. Hernia Repair
14.3.2.5. Others
14.4. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Specialty Clinics
14.5. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis/Ranking, by Company, 2018
15.3. Company Profiles
15.3.1. W. L. Gore & Associates, Inc.
15.3.1.1. Company Overview
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis
15.3.2. BD
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. Edwards Lifesciences Corporation
15.3.3.1. Company Overview
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. CryoLife, Inc.
15.3.4.1. Company Overview
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. Baxter International, Inc.
15.3.5.1. Company Overview
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Johnson & Johnson (Medical Devices Business Services, Inc.)
15.3.6.1. Company Overview
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Aesculap, Inc. (a B. Braun company)
15.3.7.1. Company Overview
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Nurami Medical Nanofiber Technology
15.3.8.1. Company Overview
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
15.3.9. Medtronic
15.3.9.1. Company Overview
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. FOC Medical S.A.
15.3.10.1. Company Overview
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis
15.3.11. Medprin Regenerative Medical Technologies Co., Ltd.
15.3.11.1. Company Overview
15.3.11.2. Growth Strategies
15.3.11.3. SWOT Analysis
15.3.12. CorMatrix, Inc.
15.3.12.1. Company Overview
15.3.12.2. Growth Strategies
15.3.12.3. SWOT Analysis
15.3.13. Terumo Corporation
15.3.13.1. Company Overview
15.3.13.2. Company Financials
15.3.13.3. Growth Strategies
15.3.13.4. SWOT Analysis
15.3.14. Lamed GmbH
15.3.14.1. Company Overview
15.3.14.2. Growth Strategies
15.3.14.3. SWOT Analysis
15.3.15. South America Implants S.A.
15.3.15.1. Company Overview
15.3.15.2. Growth Strategies
15.3.15.3. SWOT Analysis
List of Tables
Table 01: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 03: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 04: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 05: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 06: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 07: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 08: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 09: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 10: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 11: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 12: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 13: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 14: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 15: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 16: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 17: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 19: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 20: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 21: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 23: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 24: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 25: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 26: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 27: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 28: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 29: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 30: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 31: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 32: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 33: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 34: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 35: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 36: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 37: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027
Table 38: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 39: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027
Table 40: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027
Table 41: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 42: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
List of Figures
Figure 01: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 02: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn), by Product, 2018
Figure 03: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018
Figure 04: Market Overview
Figure 05: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by Product, 2018
Figure 06: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by Application, 2018
Figure 07: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by End-user, 2018
Figure 08: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by Region, 2018
Figure 09: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 10: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027
Figure 11: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Synthetic Patch, 2017–2027
Figure 12: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Biologic Patch, 2017–2027
Figure 13: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027
Figure 14: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027
Figure 15: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Cardiovascular Repair, 2017–2027
Figure 16: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Soft Tissue Repair, 2017–2027
Figure 17: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027
Figure 18: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027
Figure 19: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2017–2027
Figure 20: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Ambulatory Surgical Centers, 2017–2027
Figure 21: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Specialty Clinics, 2017–2027
Figure 22: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019–2027
Figure 23: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Region, 2018 and 2027
Figure 24: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Region, 2019–2027
Figure 25: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 26: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027
Figure 27: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027
Figure 28: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027
Figure 29: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027
Figure 30: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027
Figure 31: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 32: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country, 2018 and 2027
Figure 33: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country, 2019–2027
Figure 34: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 35: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027
Figure 36: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027
Figure 37: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027
Figure 38: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027
Figure 39: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027
Figure 40: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 41: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 42: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 43: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 44: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027
Figure 45: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027
Figure 46: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027
Figure 47: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027
Figure 48: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027
Figure 49: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 50: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 51: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 52: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 53: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027
Figure 54: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027
Figure 55: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027
Figure 56: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027
Figure 57: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027
Figure 58: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 59: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 60: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 61: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 62: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027
Figure 63: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027
Figure 64: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027
Figure 65: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027
Figure 66: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027
Figure 67: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 68: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 69: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 70: Market Position Analysis, 2018, by Tier and Size of the Company
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cardiovascular & Soft Tissue Repair Patch Market
